Literature DB >> 2928736

Endoscopic, portographic, and hemodynamic evaluation of prolonged propranolol administration in pigs with experimental portal hypertension and esophageal varices.

L S Jensen1, N Krarup, C O Juhl, T H Nielsen, J A Larsen.   

Abstract

The effect of long-term propranolol administration on esophageal varices, portocollateral shunting, portal pressure, hepatosplanchnic hemodynamics, and liver function was studied in a pig model with experimentally induced prehepatic portal hypertension and esophageal varices. Five pigs were treated with 160 mg propranolol daily from week 5 to week 24 after portal-vein banding, and five pigs served as nontreated controls. Administration of propranolol caused an initial, significant reduction (20%) of portal venous pressure, followed by a gradual increase to levels not different from control pressures. In contrast, a marked reduction of the caliber of the coronary vein and size of the esophageal varices was noticed. Twenty weeks of propranolol treatment did not change liver blood flow or liver function. We conclude that the size of the varices rather than portal venous pressure depicts the effect of propranolol treatment and suggest that the beneficial effect of propranolol on variceal bleeding can be explained by a reduction in the wall tension of the varices, initiated and maintained by a diminution of splanchnic blood flow.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2928736     DOI: 10.3109/00365528909093039

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  2 in total

Review 1.  The portal hypertension syndrome: etiology, classification, relevance, and animal models.

Authors:  Jaime Bosch; Yasuko Iwakiri
Journal:  Hepatol Int       Date:  2017-10-24       Impact factor: 6.047

2.  Experimental model of portal hypertension and esophagogastric varices in minipigs: pressure and endoscopic pilot study.

Authors:  Fauze Maluf-Filho; Alberto Meyer; Pierre Pirchner Mathias Martins; Flávio Henrique Ferreira Galvão; Luiz Augusto Carneiro D'Albuquerque
Journal:  Acta Cir Bras       Date:  2022-03-07       Impact factor: 1.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.